Abel W. Ourgessa

Abel W. Ourgessa

Auto-generated profile, based on publicly available information

Abel W. Ourgessa

Centre for Functional and Surface Functionalized Glass ‐ FunGlass Alexander Dubček University of Trenčín Trenčín Slovakia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2024 in Open Ceramics
Verified
Journal Article
Open access
AOAbel W. Ourgessa
Abel W. Ourgessa
JKJozef Kraxner
Jozef Kraxner
HEHamada Elsayed
Hamada Elsayed
DGDušan Galusek
Dušan Galusek
EBEnrico Bernardo
Enrico Bernardo

16 July 2025 in Open Ceramics
Verified
Journal Article
Open access
AOAbel W. Ourgessa
Abel W. Ourgessa
AAAhmed Gamal Abd-Elsatar
Ahmed Gamal Abd-Elsatar
MMMokhtar Mahmoud
Mokhtar Mahmoud
HEHamada Elsayed
Hamada Elsayed
JKJozef Kraxner
Jozef Kraxner
EBEnrico Bernardo
Enrico Bernardo

8 October 2025 in Journal of the American Ceramic Society
Verified
Journal Article
Open access
Ertugrul VarlikErtugrul Varlik
Ertugrul Varlik
LDLenka Drotárová
Lenka Drotárová
AOAbel W. Ourgessa
Abel W. Ourgessa
MVMartina Vitázková
Martina Vitázková
QNQaisar Nawaz
Qaisar Nawaz
MMMartin Michálek
Martin Michálek
This study investigates boron‐doped S53P4 bioactive glass (BG) scaffolds fabricated via robocasting in the context of bone regeneration strategies by comparing their mechanical performance and bioactive behavior to undoped S53P4 BG scaffolds. Three‐dimensional scaffolds with grid‐like macro architectures were fabricated using gelatin‐based composite inks containing S53P4 BG and 10 wt.% boron‐doped S53P4 BG (S53P4_10B). The scaffolds were sintered at optimized temperatures (900°C for S53P4 and 615°C for S53P4_10B), resulting in an average volumetric shrinkage of 33 vol%. Both scaffold types exhibited high porosity (∼71%) with pore sizes of 584 ± 7 µm (S53P4) and 608 ± 25 µm (S53P4_10B). Compressive strength values of 3.3 ± 1.7 MPa and 1.5 ± 0.4 MPa were respectively measured for S53P4 and for S53P4_10B BG scaffolds. Soaking in simulated body fluid for 14 days resulted in complete surface coverage with calcium‐phosphate‐rich phases, indicating high bioactivity. Antibacterial tests revealed that while crystallization reduced the inhibition zone of S53P4 scaffolds, S53P4_10B scaffolds exhibited significant antibacterial activity against E. coli and S. aureus . Cytocompatibility tests using MG‐63 and ST‐2 cell lines confirmed that scaffold extracts at concentrations ≤1% w/v were noncytotoxic. These results show that boron‐doped BG scaffolds possess bioactivity, antibacterial efficacy, and cytocompatibility, and suggest that their mechanical performance can be further tuned through scaffold design and sintering conditions.